123 related articles for article (PubMed ID: 22583849)
1. Formation of ultrafine deferasirox particles via rapid expansion of supercritical solution (RESS process) using Taguchi approach.
Asghari I; Esmaeilzadeh F
Int J Pharm; 2012 Aug; 433(1-2):149-56. PubMed ID: 22583849
[TBL] [Abstract][Full Text] [Related]
2. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process.
Thakur R; Gupta RB
Int J Pharm; 2006 Feb; 308(1-2):190-9. PubMed ID: 16352406
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production.
Sheth P; Sandhu H; Singhal D; Malick W; Shah N; Kislalioglu MS
Curr Drug Deliv; 2012 May; 9(3):269-84. PubMed ID: 22283656
[TBL] [Abstract][Full Text] [Related]
4. [Application of supercritical solution rapid expansion technology in preparation of fine pharmacal particles].
Zhang ZY; Li HL; Lei ZJ
Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1933-6. PubMed ID: 17348181
[TBL] [Abstract][Full Text] [Related]
5. In brief: Jadenu--a new formulation of deferasirox for iron overload.
Med Lett Drugs Ther; 2016 Apr; 58(1493):e56. PubMed ID: 27101213
[No Abstract] [Full Text] [Related]
6. Deferasirox-TAT(47-57) peptide conjugate as a water soluble, bifunctional iron chelator with potential use in neuromedicine.
Goswami D; Vitorino HA; Alta RY; Silvestre DM; Nomura CS; Machini MT; Espósito BP
Biometals; 2015 Oct; 28(5):869-77. PubMed ID: 26164834
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of nanopaticles of SCF-CO2 extraction of Magnolia officinalis].
He S; Zhang S; Lei Z; Zhang Z
Zhongguo Zhong Yao Za Zhi; 2009 Feb; 34(4):390-3. PubMed ID: 19459296
[TBL] [Abstract][Full Text] [Related]
8. Deferasirox--an oral agent for chronic iron overload.
Vanorden HE; Hagemann TM
Ann Pharmacother; 2006 Jun; 40(6):1110-7. PubMed ID: 16735647
[TBL] [Abstract][Full Text] [Related]
9. Supercritical fluid technology: a promising approach in pharmaceutical research.
Girotra P; Singh SK; Nagpal K
Pharm Dev Technol; 2013 Feb; 18(1):22-38. PubMed ID: 23036159
[TBL] [Abstract][Full Text] [Related]
10. A critical review on the particle generation and other applications of rapid expansion of supercritical solution.
Kumar R; Thakur AK; Banerjee N; Chaudhari P
Int J Pharm; 2021 Oct; 608():121089. PubMed ID: 34530097
[TBL] [Abstract][Full Text] [Related]
11. Crystal doping aided by rapid expansion of supercritical solutions.
Vemavarapu C; Mollan MJ; Needham TE
AAPS PharmSciTech; 2002; 3(4):E29. PubMed ID: 12916923
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
13. Micronization of dihydroartemisinin by rapid expansion of supercritical solutions.
Chingunpitak J; Puttipipatkhachorn S; Tozuka Y; Moribe K; Yamamoto K
Drug Dev Ind Pharm; 2008 Jun; 34(6):609-17. PubMed ID: 18568911
[TBL] [Abstract][Full Text] [Related]
14. Phase II clinical evaluation of deferasirox, a once-daily oral chelating agent, in pediatric patients with beta-thalassemia major.
Galanello R; Piga A; Forni GL; Bertrand Y; Foschini ML; Bordone E; Leoni G; Lavagetto A; Zappu A; Longo F; Maseruka H; Hewson N; Sechaud R; Belleli R; Alberti D
Haematologica; 2006 Oct; 91(10):1343-51. PubMed ID: 17018383
[TBL] [Abstract][Full Text] [Related]
15. Lipophilic adamantyl- or deferasirox-based conjugates of desferrioxamine B have enhanced neuroprotective capacity: implications for Parkinson disease.
Liddell JR; Obando D; Liu J; Ganio G; Volitakis I; Mok SS; Crouch PJ; White AR; Codd R
Free Radic Biol Med; 2013 Jul; 60():147-56. PubMed ID: 23391576
[TBL] [Abstract][Full Text] [Related]
16. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
[TBL] [Abstract][Full Text] [Related]
17. Formation and Characterization of Beclomethasone Dipropionate Nanoparticles Using Rapid Expansion of Supercritical Solution.
Hosseinpour M; Vatanara A; Zarghami R
Adv Pharm Bull; 2015 Sep; 5(3):343-9. PubMed ID: 26504756
[TBL] [Abstract][Full Text] [Related]
18. [Micronization of magnolia bark extract by RESS as well as dissolution and pharmacokinetics evaluation].
He S; Lei ZJ; Zhang SY; Zhang ZY
Yao Xue Xue Bao; 2009 May; 44(5):532-9. PubMed ID: 19618732
[TBL] [Abstract][Full Text] [Related]
19. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
[TBL] [Abstract][Full Text] [Related]
20. Deferasirox (Exjade): a new iron chelator.
Med Lett Drugs Ther; 2006 Apr; 48(1233):35-6. PubMed ID: 16625144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
